Sickle Cell Disease: A Retrospective Chart Review
NCT01441375 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 261
Last updated 2012-10-18
Summary
This study is a retrospective chart review of sickle cell patients and will include patients whom have received blood transfusions and those whom have not. Of the transfused patients, it will also include those whom have received chelation therapy and those whom have not.
Conditions
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Novartis Pharmaceuticals · Novartis Pharmaceuticals
Eligibility
- Min Age
- 16 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-07-31
- Primary Completion
- 2012-07-31
- Completion
- 2012-07-31
Countries
- United States
Study Locations
More Related Trials
-
Cerebrovascular Involvement in Sickle Cell Disease - Comprehensive Sickle Cell Center
NCT00005326 ·Status: COMPLETED
-
Predictors and Outcomes in Patients With Sickle Cell Disease
NCT03431935 ·Status: COMPLETED
-
Exhaled Carbon Monoxide as a Marker of Hemolysis in Sickle Cell Disease- an Exploratory Study
NCT01888614 ·Status: WITHDRAWN
-
A Pilot Study on Neuroimaging in SCD: Part of The Boston Consortium to Cure Sickle Cell Disease
NCT04166526 ·Status: RECRUITING
-
Hydroxyurea to Prevent Brain Injury in Sickle Cell Disease
NCT01389024 ·Status: COMPLETED ·Phase: PHASE2
-
Dense Red Blood Cells in Sickle Cell Children
NCT02887118 ·Status: TERMINATED
-
Long Term Effects of Hydroxyurea Therapy in Children With Sickle Cell Disease
NCT00305175 ·Status: COMPLETED
-
A Pilot Study of N-acetylcysteine in Patients With Sickle Cell Disease
NCT01800526 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Long Term Follow up in Sickle Cell Patients Treated by Hydroxyurea
NCT00480974 ·Status: COMPLETED
-
Dietary Intake and Dietary Behaviors in Adults With Sickle Cell Disease
NCT05170412 ·Status: RECRUITING
-
Gene Correction in Autologous CD34+ Hematopoietic Stem Cells (HbS to HbA) to Treat Severe Sickle Cell Disease
NCT04819841 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Hemostasis in Sickle Cell Disease--Infancy to Adulthood
NCT00005703 ·Status: COMPLETED
-
Effect of NUV001 Supplementation in Patients Suffering From Sickle Cell Disease (SCD)
NCT05789355 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Sickle Cell Anemia - A Comparative Study Between Three Ethnical Communities, a Multicenter Study
NCT01905787 ·Status: UNKNOWN
-
Qualitative Survey of Potential Exercise Activity in Adults With Sickle Cell Anemia (SCA)
NCT04181944 ·Status: COMPLETED ·Phase: NA
-
Sickle Cell Disease, Hemechip
NCT03948516 ·Status: COMPLETED
-
Motivations, Expectations, and Decision-making of Sickle Cell Patients in Clinical Research
NCT03709303 ·Status: COMPLETED
-
Exercise Capacity in Pediatric Sickle Cell Anemia
NCT01527799 ·Status: COMPLETED
-
Longitudinal Changes in Exercise Capacity in Children and Young Adults With Sickle Cell Anemia
NCT01558076 ·Status: COMPLETED
-
Metabolic and Hemodynamic Reserve in Pediatric SCA
NCT04406818 ·Status: RECRUITING ·Phase: NA
-
Pathophysiology of Acute Pain in Patients With Sickle Cell Disease
NCT03049475 ·Status: COMPLETED
-
Venous Thrombosis Biomarkers in Sickle Cell Disease and Sickle Cell Trait
NCT04349189 ·Status: COMPLETED
-
Blood Flow and Pain Crises in People With Sickle Cell Disease
NCT01568710 ·Status: COMPLETED
-
A Long-Term Follow-Up Study of Participants With Sickle Cell Disease or Transfusion Dependent β-Thalassemia Who Received EDIT-301
NCT06363760 ·Status: ENROLLING_BY_INVITATION
-
A Study to Evaluate Safety, Pharmacokinetic, and Biological Activity of INCB059872 in Subjects With Sickle Cell Disease
NCT03132324 ·Status: TERMINATED ·Phase: PHASE1